Ara
Toplam kayıt 5, listelenen: 1-5
Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?
(Galenos Yayincilik, 2012)
Aim: Bacillus Calmette-Guerin (BCG) is a standard treatment for reducing tumour recurrence and delaying progression of highrisk, non-muscle-invasive bladder tumours. However, it is not clear yet which patients are more ...
Open surgery is still gold standard for radical prostatectomy
(Galenos Yayincilik, 2014)
Open radical prostatectomy is considered as the standart of care for localised prostate cancer. It has longterm followup results and has a proven efficacy over cancer control and preservation of functional outcomes. Robot ...
The significance of tertiary Gleason pattern in prostate cancer
(Galenos Yayincilik, 2012)
Aim: Prostate cancer has a heterogenous nature and to have better prognostic prediction the prognostic importance of tertiary Gleason pattern (TGP) is debated today. Although the prognostic significance of TGP is accepted ...
Metabolic syndrome in the etiology of benign prostatic hyperplasia/lower urinary tract symptoms
(Galenos Yayincilik, 2013)
Metabolic syndrome is a growing health burden in the world and Turkish population, affecting the length and the quality of life. Although it involves some interrelated metabolic abnormalities like central obesity, dyslipidemia, ...
Is intravesical BCG treatment necessary and/or sufficient?
(Galenos Yayincilik, 2013)
Intravesical BCG treatment has been used over 3 decades in the treatment of non-muscle invasive bladder cancer. Although the exact mechanism of its action is not clear, its clinical efficiency has been proven. Numerous ...